These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9487547)

  • 1. Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers.
    Mooren FC; Berthold A; Domschke W; Kreuter J
    Pharm Res; 1998 Jan; 15(1):58-65. PubMed ID: 9487547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
    Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.
    Oosegi T; Onishi H; Machida Y
    Int J Pharm; 2008 Feb; 348(1-2):80-8. PubMed ID: 17714892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate.
    Lim ST; Forbes B; Martin GP; Brown MB
    AAPS PharmSciTech; 2001 Oct; 2(4):20. PubMed ID: 14727857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
    Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A
    J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
    Onishi H; Kikuchi H; Machida Y
    Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.
    van der Lubben IM; van Opdorp FA; Hengeveld MR; Onderwater JJ; Koerten HK; Verhoef JC; Borchard G; Junginger HE
    J Drug Target; 2002 Sep; 10(6):449-56. PubMed ID: 12575734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).
    Artursson P; Lindmark T; Davis SS; Illum L
    Pharm Res; 1994 Sep; 11(9):1358-61. PubMed ID: 7816770
    [No Abstract]   [Full Text] [Related]  

  • 10. Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils.
    Hejazi R; Amiji M
    Pharm Dev Technol; 2003 Aug; 8(3):253-62. PubMed ID: 12901691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall.
    Grabnar I; Bogataj M; Mrhar A
    Int J Pharm; 2003 Apr; 256(1-2):167-73. PubMed ID: 12695023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of polymers weight ratio and pH of polymers solution on the characteristics of chitosan-carboxymethyl cellulose microspheres containing theophylline.
    Bayomi MA
    Boll Chim Farm; 2003 Oct; 142(8):336-42. PubMed ID: 15040463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of in vitro and in vivo release of prednisolone from the conjugate of glycol-chitosan and succinyl-prednisolone.
    Onishi H; Saito Y; Sasatsu M; Machida Y
    Int J Pharm; 2011 May; 410(1-2):17-22. PubMed ID: 21397670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
    Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
    J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclase-activating polypeptide).
    Langoth N; Bernkop-Schnürch A; Kurka P
    Pharm Res; 2005 Dec; 22(12):2045-50. PubMed ID: 16132338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin loaded chitosan microspheres. Correlation between the erosion process and release kinetics.
    Orienti I; Aiedeh K; Gianasi E; Bertasi V; Zecchi V
    J Microencapsul; 1996; 13(4):463-72. PubMed ID: 8808782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of interleukin-2 from chitosan microspheres.
    Ozbaş-Turan S; Akbuğa J; Aral C
    J Pharm Sci; 2002 May; 91(5):1245-51. PubMed ID: 11977100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of multiparticulate system for targeted drug delivery to colon.
    Chourasia MK; Jain SK
    Drug Deliv; 2004; 11(3):201-7. PubMed ID: 15204639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular bioavailability of topical prednisolone preparations.
    Olejnik O; Weisbecker CA
    Clin Ther; 1990; 12(1):2-11. PubMed ID: 2328525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.